Novartis employs a variety of ACD/Labs software in support of structure elucidation and structure verification in pharmaceutical development and post-commercialization. Here they present:

  • Their workflow for structure identification and elucidation for impurities and degradants
  • Time-savings from automated structure verification—a system supporting research chemists for several years
  • The importance of integrated, centralized data management in impurity identification, forced degradation studies, and stability studies